Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks
Clinical trial NCT04410965 · COMPLETED
Trial details
- NCT number
- NCT04410965
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2021-07-12
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.